ENDRA Life Sciences Inc (NASDAQ: NDRA) is -99.74% lower on its value in year-to-date trading and has touched a low of $0.18 and a high of $139.50 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NDRA stock was last observed hovering at around $0.25 in the last trading session, with the day’s gains setting it 0.03%.
Currently trading at $0.28, the stock is 10.98% and 3.28% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.22 million and changing 10.93% at the moment leaves the stock -98.42% off its SMA200. NDRA registered -99.39% loss for a year compared to 6-month loss of -98.29%. The firm has a 50-day simple moving average (SMA 50) of $0.27022 and a 200-day simple moving average (SMA200) of $17.665565.
The stock witnessed a 37.78% gain in the last 1 month and extending the period to 3 months gives it a -91.62%, and is -0.36% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 21.24% over the week and 23.31% over the month.
ENDRA Life Sciences Inc (NDRA) has around 21 employees, a market worth around $5.61M and $0.00M in sales. Distance from 52-week low is 53.80% and -99.80% from its 52-week high. The company has generated returns on investments over the last 12 months (-105.20%).
The EPS is expected to grow by 85.97% this year.
ENDRA Life Sciences Inc (NDRA) Top Institutional Holders
15.0 institutions hold shares in ENDRA Life Sciences Inc (NDRA), with institutional investors hold 0.09% of the company’s shares. The shares outstanding are 18.14M, and float is at 18.14M with Short Float at 3.96%. Institutions hold 0.09% of the Float.
ENDRA Life Sciences Inc (NDRA) Insider Activity
The most recent transaction is an insider purchase by UBS Group AG, the company’s 10% Owner. SEC filings show that UBS Group AG bought 3,715 shares of the company’s common stock on Aug 27 ’24 at a price of $0.55 per share for a total of $2052.0. Following the purchase, the insider now owns 0.15 million shares.
